1. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol. 2008; 7:939–950.
Article
2. Moulin DE, Hagen N, Feasby TE, Amireh R, Hahn A. Pain in Guillain-Barré syndrome. Neurology. 1997; 48:328–331.
Article
3. Asahina M, Kuwabara S, Suzuki A, Hattori T. Autonomic function in demyelinating and axonal subtypes of Guillain-Barré syndrome. Acta Neurol Scand. 2002; 105:44–50.
Article
4. Hasser EM, Moffitt JA. Regulation of sympathetic nervous system function after cardiovascular deconditioning. Ann N Y Acad Sci. 2001; 940:454–468.
Article
5. Kloesel B, Hickson LJ. Severe hyponatremia as the initial sign preceding guillain-barr syndrome, an acute inflammatory demyelinating polyneuropathy: a case report. Case Rep Neurol Med. 2013; 2013:923602.
Article
6. Saifudheen K, Jose J, Gafoor VA, Musthafa M. Guillain-Barre syndrome and SIADH. Neurology. 2011; 76:701–704.
Article
7. Hoffmann O, Reuter U, Schielke E, Weber JR. SIADH as the first symptom of Guillain-Barré syndrome. Neurology. 1999; 53:1365.
Article
8. Ramanathan S, McMeniman J, Cabela R, Holmes-Walker DJ, Fung VS. SIADH and dysautonomia as the initial presentation of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2012; 83:344–345.
Article
9. Singh NK, Jaiswal AK, Misra S, Srivastava PK. Assessment of autonomic dysfunction in Guillain-Barré syndrome and its prognostic implications. Acta Neurol Scand. 1987; 75:101–105.
Article
10. Burns TM, Lawn ND, Low PA, Camilleri M, Wijdicks EF. Adynamic ileus in severe Guillain-Barré syndrome. Muscle Nerve. 2001; 24:963–965.
Article
11. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore). 1969; 48:173–215.
12. de Jager AE, Sluiter HJ. Clinical signs in severe Guillain-Barré syndrome: analysis of 63 patients. J Neurol Sci. 1991; 104:143–150.
Article
13. Flachenecker P, Wermuth P, Hartung HP, Reiners K. Quantitative assessment of cardiovascular autonomic function in Guillain-Barre syndrome. Ann Neurol. 1997; 42:171–179.
Article
14. Dimario FJ Jr, Edwards C. Autonomic dysfunction in childhood Guillain-Barré syndrome. J Child Neurol. 2012; 27:581–586.
Article
15. Hund EF, Borel CO, Cornblath DR, Hanley DF, McKhann GM. Intensive management and treatment of severe Guillain-Barré syndrome. Crit Care Med. 1993; 21:433–446.
Article
16. Drossman DA. Rome III: the new criteria. Chin J Dig Dis. 2006; 7:181–185.
Article
17. Turchetti A, Guglielmi S, Fossati C, Matrunola M, Corrado G. Gastric emptying time in cyclic vomiting syndrome in children. Eur Rev Med Pharmacol Sci. 2004; 8:295–298.
18. Sim YJ, Kim JM, Kwon S, Choe BH. Clinical experience with amitriptyline for management of children with cyclic vomiting syndrome. Korean J Pediatr. 2009; 52:538–543.
Article
19. Prakash C, Clouse RE. Cyclic vomiting syndrome in adults: clinical features and response to tricyclic antidepressants. Am J Gastroenterol. 1999; 94:2855–2860.
Article
20. Yang HR, Ko JS, Seo JK. A study on the disease course and prognosis of cyclic vomiting syndrome. J Korean Pediatr Soc. 2001; 44:1141–1156.